{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:24:10Z","timestamp":1786926250476,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o de apoio \u00e0 pesquisa do Estado de Sao Paulo - FAPESP","award":["2016\/19798-7"],"award-info":[{"award-number":["2016\/19798-7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Left ventricular hypertrophy is a risk factor for cardiovascular mortality in patients on peritoneal dialysis (PD). Because icodextrin has a greater ultrafiltration power compared with glucose-based solutions for long dwell, it could improve left ventricular mass by reducing fluid overload. This was a randomized clinical trial that included patients on PD recruited from 2 teaching hospitals, in Sao Paulo\u2014Brazil. Patients were allocated to the control glucose group (GLU) or the intervention icodextrin (ICO) group. Clinical and cardiac magnetic resonance image (MRI) parameters were evaluated at baseline and 6\u00a0months after randomization. The primary outcome was the change in left ventricular mass adjusted by surface area (\u0394LVMI), measured by cardiac MRI. A total of 22 patients completed the study (GLU, N\u2009=\u200912 and ICO, N\u2009=\u200910). Baseline characteristics such as age, sex, underlying disease, and time on dialysis were similar in both groups. At baseline, 17 patients (77.3%) presented with left ventricular hypertrophy with no difference between groups (p\u2009=\u20090.748). According to the total body water (TBW)\/extracellular water (ECW) ratio, 36.8% and 80% of patients from GLU and ICO groups, respectively, were considered hypervolemic (p\u2009=\u20090.044). During follow-up, \u0394LVMI was 3.9\u00a0g\/m (\u2212\u00a010.7, 2.2) in GLU and 5.2 (\u2212\u00a026.8, 16.8) in ICO group (p\u2009=\u20090.651). \u0394LVMI correlated with change in brain natriuretic peptide (r\u2009=\u20090.566, p\u2009=\u20090.044), which remained significant in a multiple regression analysis. The use of the icodextrin-based solution in prevalent patients on PD compared with a glucose-based solution was not able to improve LMV. A larger randomized trial with a longer follow-up period may be needed to show changes in LVM in this patient population.<\/jats:p><jats:p>Trial registration: this study has been registered at ReBEC (Registro Brasileiro de Ensaios Clinicos) under the identification #RBR-2mzhmj2, available at: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ensaiosclinicos.gov.br\/pesquisador\">https:\/\/ensaiosclinicos.gov.br\/pesquisador<\/jats:ext-link>.<\/jats:p>","DOI":"10.1038\/s41598-022-20157-z","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T10:14:33Z","timestamp":1663841673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Lilian","family":"Cordeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walther Yoshiharu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Claudia C.","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia F.","family":"Canziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Karla R. P.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedito J.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Abensur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M. A.","family":"Moys\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"4","key":"20157_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000435838","volume":"5","author":"L Di Lullo","year":"2015","unstructured":"Di Lullo, L., Gorini, A., Russo, D., Santoboni, A. & Ronco, C. Left ventricular hypertrophy in chronic kidney disease patients: From pathophysiology to treatment. Cardiorenal. Med. 5(4), 254\u2013266 (2015) (Epub 2015\/12\/10).","journal-title":"Cardiorenal. Med."},{"issue":"4","key":"20157_CR2","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","volume":"65","author":"C Zoccali","year":"2004","unstructured":"Zoccali, C. et al. Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression. Kidney Int. 65(4), 1492\u20131498 (2004) (Epub 2004\/04\/17).","journal-title":"Kidney Int."},{"issue":"6","key":"20157_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11255-013-0615-8","volume":"46","author":"RA Cader","year":"2014","unstructured":"Cader, R. A., Ibrahim, O. A., Paul, S., Gafor, H. A. & Mohd, R. Left ventricular hypertrophy and chronic fluid overload in peritoneal dialysis patients. Int. Urol. Nephrol. 46(6), 1209\u20131215 (2014) (Epub 2013\/12\/07).","journal-title":"Int. Urol. Nephrol."},{"issue":"11","key":"20157_CR4","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/ndt\/gfg371","volume":"18","author":"RM Fagugli","year":"2003","unstructured":"Fagugli, R. M. et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol. Dial. Transplant. 18(11), 2332\u20132338 (2003) (Epub 2003\/10\/11).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"20157_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3747\/pdi.2009.00264","volume":"31","author":"H Qi","year":"2011","unstructured":"Qi, H., Xu, C., Yan, H. & Ma, J. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: A meta-analysis of randomized controlled trials. Perit. Dial. Int. 31(2), 179\u2013188 (2011).","journal-title":"Perit. Dial. Int."},{"issue":"3","key":"20157_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/089686080602600310","volume":"26","author":"TK Jeloka","year":"2006","unstructured":"Jeloka, T. K. et al. What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients?. Perit. Dial. Int. 26(3), 336\u2013340 (2006) (Epub 2006\/05\/26).","journal-title":"Perit. Dial. Int."},{"key":"20157_CR7","first-page":"9","volume":"29","author":"T Hiramatsu","year":"2013","unstructured":"Hiramatsu, T. et al. Icodextrin eliminates phosphate and ameliorates cardiac hypertrophy and valvular calcification in patients with end-stage renal disease and diabetes mellitus undergoing peritoneal dialysis. Adv. Perit. Dial. 29, 9\u201313 (2013) (Epub 2013\/12\/19).","journal-title":"Adv. Perit. Dial."},{"issue":"4","key":"20157_CR8","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1046\/j.1523-1755.2003.00887.x","volume":"63","author":"CJ Konings","year":"2003","unstructured":"Konings, C. J. et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized study. Kidney Int. 63(4), 1556\u20131563 (2003).","journal-title":"Kidney Int."},{"key":"20157_CR9","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1038\/sj.ki.5002613","volume":"108","author":"R Paniagua","year":"2008","unstructured":"Paniagua, R. et al. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int. Suppl. 108, S125\u2013S130 (2008) (Epub 2008\/05\/03).","journal-title":"Kidney Int. Suppl."},{"key":"20157_CR10","first-page":"14","volume":"29","author":"I Oba","year":"2013","unstructured":"Oba, I., Shinozaki, M., Harada, K., Mori, T. & Kanai, H. Icodextrin-based continuous ambulatory peritoneal dialysis therapy effectively reduces left ventricular mass index and protects cardiac function in patients with end-stage renal disease. Adv. Perit. Dial. 29, 14\u201318 (2013).","journal-title":"Adv. Perit. Dial."},{"issue":"1","key":"20157_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12882-018-0912-7","volume":"19","author":"JB Chen","year":"2018","unstructured":"Chen, J. B. et al. Longitudinal analysis of cardiac structure and function in incident-automated peritoneal dialysis: Comparison between icodextrin solution and glucose-based solution. BMC Nephrol. 19(1), 109 (2018) (Epub 2018\/05\/10).","journal-title":"BMC Nephrol."},{"issue":"11","key":"20157_CR12","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/ASN.2012100987","volume":"24","author":"PK Li","year":"2013","unstructured":"Li, P. K. et al. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J. Am. Soc. Nephrol. 24(11), 1889\u20131900 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"20157_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-8703(94)90636-X","volume":"128","author":"PM Pattynama","year":"1994","unstructured":"Pattynama, P. M., De Roos, A., Van der Wall, E. E. & Van Voorthuisen, A. E. Evaluation of cardiac function with magnetic resonance imaging. Am. Heart J. 128(3), 595\u2013607 (1994) (Epub 1994\/09\/01).","journal-title":"Am. Heart J."},{"issue":"6","key":"20157_CR14","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1046\/j.1523-1755.1999.00786.x","volume":"56","author":"GA Stewart","year":"1999","unstructured":"Stewart, G. A. et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int. 56(6), 2248\u20132253 (1999).","journal-title":"Kidney Int."},{"issue":"3","key":"20157_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cjca.2012.07.013","volume":"29","author":"BD Jakubovic","year":"2013","unstructured":"Jakubovic, B. D. et al. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease. Can. J. Cardiol. 29(3), 384\u2013390 (2013) (Epub 2012\/10\/30).","journal-title":"Can. J. Cardiol."},{"issue":"3","key":"20157_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2114\/jpa.23.93","volume":"23","author":"S Demura","year":"2004","unstructured":"Demura, S., Sato, S. & Kitabayashi, T. Percentage of total body fat as estimated by three automatic bioelectrical impedance analyzers. J. Physiol. Anthropol. Appl. Human Sci. 23(3), 93\u201399 (2004) (Epub 2004\/06\/10).","journal-title":"J. Physiol. Anthropol. Appl. Human Sci."},{"issue":"1","key":"20157_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12968-017-0327-9","volume":"19","author":"SE Petersen","year":"2017","unstructured":"Petersen, S. E. et al. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J. Cardiovasc. Magn. Reson. 19(1), 18 (2017) (Epub 2017\/02\/10).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"3","key":"20157_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/0896860819895356","volume":"40","author":"AY Wang","year":"2020","unstructured":"Wang, A. Y. et al. International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit. Dial. Int. 40(3), 310\u2013319 (2020) (Epub 2020\/02\/18).","journal-title":"Perit. Dial. Int."},{"issue":"6","key":"20157_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000363417","volume":"39","author":"SA Silver","year":"2014","unstructured":"Silver, S. A., Harel, Z. & Perl, J. Practical considerations when prescribing icodextrin: A narrative review. Am. J. Nephrol. 39(6), 515\u2013527 (2014) (Epub 2014\/06\/14).","journal-title":"Am. J. Nephrol."},{"issue":"4","key":"20157_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/089686080902900409","volume":"29","author":"R Paniagua","year":"2009","unstructured":"Paniagua, R. et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit. Dial. Int. 29(4), 422\u2013432 (2009) (Epub 2009\/07\/16).","journal-title":"Perit. Dial. Int."},{"issue":"11","key":"20157_CR21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/ndt\/gfv247","volume":"30","author":"TP de Moraes","year":"2015","unstructured":"de Moraes, T. P. et al. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: Results of a randomized controlled trial (STARCH). Nephrol. Dial. Transplant. 30(11), 1905\u20131911 (2015) (Epub 2015\/06\/13).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"20157_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jacl.2014.03.007","volume":"8","author":"AD Sniderman","year":"2014","unstructured":"Sniderman, A. D., Sloand, J. A., Li, P. K., Story, K. & Bargman, J. M. Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA\/EDEN trials. J. Clin. Lipidol. 8(4), 441\u2013447 (2014) (Epub 2014\/08\/12).","journal-title":"J. Clin. Lipidol."},{"issue":"4","key":"20157_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000322617","volume":"31","author":"YJ Luo","year":"2011","unstructured":"Luo, Y. J., Lu, X. H., Woods, F. & Wang, T. Volume control in peritoneal dialysis patients guided by bioimpedance spectroscopy assessment. Blood Purif. 31(4), 296\u2013302 (2011) (Epub 2011\/01\/19).","journal-title":"Blood Purif."},{"key":"20157_CR24","first-page":"65","volume":"27","author":"E Hur","year":"2011","unstructured":"Hur, E. et al. Bioimpedance spectroscopy for the detection of hypervolemia in peritoneal dialysis patients. Adv. Perit. Dial. 27, 65\u201370 (2011) (Epub 2011\/11\/12).","journal-title":"Adv. Perit. Dial."},{"issue":"3","key":"20157_CR25","first-page":"190","volume":"15","author":"J Huting","year":"1992","unstructured":"Huting, J. & Alpert, M. A. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation. Clin. Cardiol. 15(3), 190\u2013196 (1992) (Epub 1992\/03\/01).","journal-title":"Clin. Cardiol."},{"issue":"1","key":"20157_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.23876\/j.krcp.20.153","volume":"40","author":"T Tangwonglert","year":"2021","unstructured":"Tangwonglert, T. & Davenport, A. Changes in extracellular water and left ventricular mass in peritoneal dialysis patients. Kidney Res. Clin. Pract. 40(1), 135\u2013142 (2021) (Epub 2021\/04\/02).","journal-title":"Kidney Res. Clin. Pract."},{"issue":"7","key":"20157_CR27","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/ndt\/16.7.1459","volume":"16","author":"G Enia","year":"2001","unstructured":"Enia, G. et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol. Dial. Transplant. 16(7), 1459\u20131464 (2001) (Epub 2001\/06\/28).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"20157_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2215\/CJN.03820907","volume":"3","author":"R Paniagua","year":"2008","unstructured":"Paniagua, R. et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: Results from the ADEMEX trial. Clin. J. Am. Soc. Nephrol. 3(2), 407\u2013415 (2008) (Epub 2008\/01\/18).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"20157_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000343286","volume":"36","author":"A Davenport","year":"2012","unstructured":"Davenport, A. Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am. J. Nephrol. 36(4), 371\u2013376 (2012) (Epub 2012\/10\/12).","journal-title":"Am. J. Nephrol."},{"key":"20157_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcvm.2017.00010","volume":"4","author":"S Niizuma","year":"2017","unstructured":"Niizuma, S., Iwanaga, Y., Yahata, T. & Miyazaki, S. Renocardiovascular biomarkers: From the perspective of managing chronic kidney disease and cardiovascular disease. Front. Cardiovasc. Med. 4, 10 (2017) (Epub 2017\/03\/23).","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"20157_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.ajkd.2019.12.017","volume":"76","author":"TG Harrison","year":"2020","unstructured":"Harrison, T. G. et al. Association of NT-proBNP and BNP with future clinical outcomes in patients with ESKD: A systematic review and meta-analysis. Am. J. Kidney Dis. 76(2), 233\u2013247 (2020) (Epub 2020\/05\/11).","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"20157_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1053\/j.ajkd.2019.10.004","volume":"75","author":"K Goossen","year":"2020","unstructured":"Goossen, K. et al. Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: An enriched systematic review and meta-analysis of randomized controlled trials. Am. J. Kidney Dis. 75(6), 830\u2013846 (2020) (Epub 2020\/02\/09).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20157-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20157-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20157-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T23:05:23Z","timestamp":1663887923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20157-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20157"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20157-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"14 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15776"}}